D475-2052 Screening compound: 3-methyl-1-[4-methyl-5-(pyrrolidine-1-carbonyl)-1,3-thiazol-2-yl]-4-[(4-methylphenyl)methyl]-1H-pyrazol-5-ol

D475-2052 Screening compound: 3-methyl-1-[4-methyl-5-(pyrrolidine-1-carbonyl)-1,3-thiazol-2-yl]-4-[(4-methylphenyl)methyl]-1H-pyrazol-5-ol
D475-2052 Screening compound: 3-methyl-1-[4-methyl-5-(pyrrolidine-1-carbonyl)-1,3-thiazol-2-yl]-4-[(4-methylphenyl)methyl]-1H-pyrazol-5-ol alternative view

Chemical Structure Depiction of ChemDiv screening compound D475-2052
3-methyl-1-[4-methyl-5-(pyrrolidine-1-carbonyl)-1,3-thiazol-2-yl]-4-[(4-methylphenyl)methyl]-1H-pyrazol-5-ol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D475-2052

Molecular Formula

C21H24N4O2S (C21 H24 N4 O2 S)

Compound Name

3-methyl-1-[4-methyl-5-(pyrrolidine-1-carbonyl)-1,3-thiazol-2-yl]-4-[(4-methylphenyl)methyl]-1H-pyrazol-5-ol

IUPAC name

3-methyl-1-[4-methyl-5-(pyrrolidine-1-carbonyl)-13-thiazol-2-yl]-4-[(4-methylphenyl)methyl]-1H-pyrazol-5-ol

SMILES

Cc(c(Cc1ccc(C)cc1)c1O)nn1-c1nc(C)c(C(N2CCCC2)=O)s1

InChI

InChI=1S/C21H24N4O2S/c1-13-6-8-16(9-7-13)12-17-14(2)23-25(19(17)26)21-22-15(3)18(28-21)20(27)24-10-4-5-11-24/h6-9,26H,4-5,10-12H2,1-3H3

InChI Key

PTOYASHWVNLTNA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27588587

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

396.51

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.745

Distribution Coefficient, logD

2.335

Water Solubility, LogSw

-3.95

Polar Surface Area

57.228

Acid Dissociation Constant (pKa)

6.51

Base Dissociation Constant (pKb)

7.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.10

D475-2052 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

RNA-Protein Interaction Inhibitors Library (1986 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with D475-2052 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D475-2052?
Check Price and Availability of D475-2052, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D475-2052 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D475-2052
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D475-2052
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D475-2052 available by request